Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $34.5500 (0.85%) ($34.5500 - $34.5500) on Thu. Jun. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 50 | Latest Price | $34.5500(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.1% a day on average for past five trading days. | Weekly Trend | TGTX advances 0.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) IBB(59%) IWO(59%) ARKK(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.725% in a week (0% probabilities). VIXM(-45%) VXX(-38%) UUP(-18%) UNG(-3%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $34.94 | 5 Day Moving Average | $34.34(0.61%) | 10 Day Moving Average | $33.94(1.8%) | 20 Day Moving Average | $34.94(-1.12%) | To recent high | -31.4% | To recent low | 6.5% | Market Cap | $4.376b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |